INTRODUCTION
============

Arthrofibrosis after total knee arthroplasty (TKA), the incidence of which is reported as 3-10% in the literature \[[@R1]-[@R4]\], remains an unsolved problem. As a result of the permanent painful limited range of motion, many patients experience a pronounced functional impairment of the affected knee, despite the TKA having been implanted correctly. Although risk factors such as the preoperative range of motion, previous surgery or diabetes mellitus are identified \[[@R3]-[@R5]\], the precise aetiology has remained unclear to date \[[@R3],[@R6]-[@R8]\]. This means that therapy can only be symptom-oriented at present, ranging from arthroscopic and open arthrolysis to revision arthroplasty \[[@R2],[@R3],[@R9],[@R10]\]. However, regardless of the procedure used, the results are largely unsatisfactory \[[@R3],[@R9]\].

Without a clear pathomechanism, it has not been possible to develop a prophylaxis against arthrofibrosis up to now. However, cytokines in the synovial fluid, in particular *bone morphogenetic protein 2* (BMP-2), appear to play a central role in the pathogenesis of arthrofibrosis. In a previous study, we demonstrated elevated concentrations of BMP-2 in the synovial fluid in arthrofibrosis after TKA \[[@R11]\]. Apart from its inflammatory effect, BMP-2 is known in particular as a potent inductor of heterotopic ossifications (HO) in tissue \[[@R12]-[@R15]\]. Not only fibrosis of the soft tissues but also an increased incidence of HO were thus observed in further studies on arthrofibrosis after TKA \[[@R1],[@R16]-[@R19]\].

In the future, it might be possible to reduce HO in the periarticular soft tissue by influencing the BMP-2 pathway and thus provide a prophylaxis against arthrofibrosis in risk patients, comparable to the established ossification prophylaxis in hip arthroplasty \[[@R20],[@R21]\].

The hypothesis in the present investigation was therefore that the limited flexion in arthrofibrosis after TKA is caused by HO in the anterior soft tissue, the quantity of which depends on the BMP-2 concentration in the synovial fluid.

MATERIALS AND METHODOLOGY
=========================

Patients with primary arthrofibrosis after TKA were included in this retrospective study. All of the study patients are part of a patient population of a previous study on BMP-2 expression in synoviocytes in patients with arthrofibrosis after TKA \[[@R11]\]. The study protocol was approved by the institutional review board and all patients gave their informed consent. Age, sex, side and period since primary implantation were documented for each patient.

Up to now, the literature has not included a uniform definition of arthrofibrosis after TKA \[[@R3]\]. In the present study protocol, arthrofibrosis was defined as a painful limitation of flexion \< 90° and an extension deficit \> 10°, according to the classification of Yercan \[[@R22]\]. A pain duration of at least 6 months since implantation, a resting pain of \> 5 and a weight bearing pain of \> 7 on a visual analogue scale (VAS) were also defined as inclusion criteria regarding pain.

If there were signs of secondary arthrofibrosis present like infection, loosening, instability, impingement or malalignment, these knees were excluded. In all patients the same diagnostic algorithm was used. Every patient was clinically investigated by the senior author. At this point instability in the coronal (collateral ligamants) or sagittal plane (PCL) was detected. After that whole leg standing a.p. radiographs and lateral radiographs for exclusion of loosening, component malalignment and static impingement due to component oversizing were performed in all cases. For exclusion of infection all patients received blood sample analysis for blood leukocyte count, CRP and ESR such as joint fluid aspiration with following microbiological testing (14 days incubation). A pathological finding in one or more investigation lead to the exclusion of the patient.

Joint fluid was collected *via*aspiration in all knees once during the study. A minimum of 5 ml of synovial fluid was immediately cryoconserved and stored at -20°C until examination. The measurement of the concentration of BMP-2 was performed with ELISA.

BMP-2 ELISA
===========

The \"Quantikine BMP-2 Immunoassay Kit\" was used for analysing the concentration of BMP-2 in the synovial fluid according to the manufacturer\'s protocol (R&D systems, Minnesota, USA). The technique of this assay is a quantitative sandwich enzyme immunoassay. Extinction was measured in a microplate reader at a wavelength of 450nm.

Radiological Investigation
--------------------------

The lateral digital radiographs of each patient, which were done within the context of routine clinical diagnostics, were evaluated according to standardised procedures. Of the original 10 patients, 2 had to be subsequently excluded due to the lack of digital radiographs. The digital images of the remaining 8 patients were evaluated using image processing software (ImageJ 1.45l, Maryland, USA). The individual grey scale values of defined points were recorded as a measure for the density of the tissue \[[@R23]\].

In order to examine the interindividual comparability of the images, the grey scale values of standardised measuring points (air, cutis, subcutis, gastrocnemius muscle) were first compared using the image processing software.

For qualitative assessment of the soft-tissue density in the joint capsule / HO, the grey scale values in the area of the joint capsule of the suprapatellar pouch were evaluated. This was done by measuring a "region of interest" with a defined measuring square of 24mm^2^ (Fig. **[1](#F1){ref-type="fig"}**).

Statistics
----------

Descriptive statistics (mean, minimum, maximum and standard deviations) were calculated from the measured data. Correlation analysis was done with the Pearson test. P=0.05 was defined as the level of significance.

RESULTS
=======

The average age of the 5 male and 3 female patients included was 67.5 ± 9.4 years. The side distribution of left to right knees showed a ratio of 7:1. The duration since primary implantation was on average 26.6 ± 15.7 months.

BMP-2 ELISA
===========

The concentration of BMP-2 in the synovial fluid of the analysed patients with arthrofibrosis after TKA was 24.3 ± 6.9 pg/ml.

Radiological Investigation
--------------------------

The evaluation of the digital, lateral radiographs showed only slight differences in the grey scales of the reference tissue, so that the subsequent evaluation of the anterior soft tissues was possible without correction in the sense of a standardisation. The grey scale values of air were on average 2 ± 1.4. The cutis showed average grey scale values of 10.9 ± 2.7, the subcutis 26.9 ± 8.4 and the gastrocnemius muscle 69.8 ± 11.6 (Fig. **[2](#F2){ref-type="fig"}**).

Correlation Analysis Between BMP-2 Concentration and Soft-Tissue Density
------------------------------------------------------------------------

The grey scale values of the measuring square in the area of the anterior knee capsule were on average 136.2 ± 34.5.

In the correlation analysis, a close linear correlation was found between the concentration of BMP-2 in the synovial fluid and the grey scale values of the anterior joint capsule as a measure of tissue density (R=0.84, p = 0.009) (Fig. **[3](#F3){ref-type="fig"}**).

DISCUSSION
==========

In this investigation, we were able to show that there is a connection between BMP-2 concentration in the synovial fluid and soft-tissue density of the anterior joint capsule in patients with arthrofibrosis after TKA. Although this increased density could be differentiated radiologically (Fig. **[4](#F4){ref-type="fig"}**), it did not reach the density of bone, so that radiologically visible HO were not present in any of the cases.

This is consistent with the observations of Freeman *et al*. \[[@R17]\]. On the basis of micro-CT and histology of arthrofibrosis after TKA, they demonstrated mineralised areas in the soft tissue with a density equivalent to bone, which were not identifiable as ossifications in conventional radiographs. The authors suspected the cause to be the insufficient resolution of conventional radiographs to reveal the ossifications present. However, the amount of ectopic bone in the soft tissue correlated with the extent of the patients\' limitation of range of motion \[[@R17]\]. This leads to the conclusion that HO may already be present histologically, with clinically relevant impairment of flexion, although they are not detectable in conventional radiographs.

In the pathogenesis of arthrofibrosis, the persistence of physiological inflammation leads to a transdifferentiation of fibroblasts \[[@R1],[@R7],[@R17],[@R24],[@R25]\], followed by fibrosis of the soft tissue \[[@R1],[@R18],[@R19],[@R26]\]. Within the context of this tissue transformation, further studies have demonstrated HO in arthrofibrosis \[[@R1],[@R16]-[@R19]\].

A connection between BMP-2 concentration in the synovial fluid and HO in arthrofibrosis after TKA has not been described in the literature to date.

In a previous study, we showed an elevated BMP-2 concentration in the synovial fluid (24.3 ± 6.9 pg/mL) and upregulation of BMP-2 in the synoviocytes in arthrofibrosis after TKA. The control group of non-operated knees showed a significantly lower BMP-2 concentration of 5.9 ± 4.8 pg/mL \[[@R11]\]. However, a "normal" range of BMP-2 concentration in the synovial fluid has not been described before.

Apart from its proinflammatory function, BMP-2 is also a strong inductor of heterotopic ossifications \[[@R11]-[@R15]\]. *In vitro*, it causes the osteogenic differentiation of human mesenchymal stem cells \[[@R27]\]. Within the context of a prolonged inflammation in arthrofibrosis, BMP-2 may therefore induce these HO in the soft tissue \[[@R28]\]. Corresponding to this, the upregulation of BMP-2 and BMP-9 has been shown in patients with HO after hip arthroplasty \[[@R29],[@R30]\].

In clinical application, chronic painful inflammations with pronounced HO have been observed after the application of BMP-2 in spondylodeses \[[@R31]-[@R33]\] and in fracture healing \[[@R34]\].

One limitation of the present study is the small number of cases, resulting from the low rate of primary arthrofibroses

after TKA without any secondary cause. This low number of patients corresponds to a low power of this study, i.e. it is not possible to exclude a correlation between BMP-2 and soft tissue density if it had not been detected. But based on the statistically significant correlation even the low number of patients is sufficient to show a link between BMP-2 and soft-tissue density. A further limitation of this study is the absence of histological examinations of the altered joint capsule tissue. This was not possible in retrospect, due to the retrospective design of the study.

CONCLUSION
==========

With the present study, we have shown a connection between the BMP-2 concentration in the synovial fluid and soft-tissue density in the area of the anterior joint capsule in arthrofibrosis after TKA. In the future, it may be possible to influence the BMP-2 pathway as an inductor of HO in risk patients as a prophylaxis against arthrofibrosis after TKA.
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